Department of Justice
Office of the Inspector General
Evaluation & Inspections Division
DEA Diversion Control Program Questionnaire
INTRODUCTION
The Department of Justice Office of the Inspector General is conducting a review of the Drug Enforcement Administration’s (DEA) diversion control program. Specifically, we are examining the DEA’s enforcement efforts regarding controlled pharmaceutical diversion. We completed our last review in this area in October 2002.
As part of the review, we are conducting this survey of diversion investigator, special agent, or other Group Supervisors involved in diversion control to obtain information regarding DEA’s diversion control operations. Your input is very important to us. For tracking purposes, it is important that you include your name on the survey, but your identity will remain confidential and will not be used in any survey results. All responses will be reported in the aggregate only.
DIRECTIONS: This survey should be completed by every Group Supervisor directly responsible for coordinating and supervising either:
- a DEA diversion group,
- a DEA enforcement group that focuses on diversion, or
- a Tactical Diversion Squad or other task force devoted to diversion control.
Unless otherwise noted, please answer the survey questions as they relate to current operations for your group only.
We prefer that you answer this questionnaire electronically. To do so, please click your cursor in the indicated shaded area and type your response. After you have completed the questionnaire, please save the document and e-mail it as an attachment to the following address: xxx@usdoj.gov. If necessary, you may print out the questionnaire, fill it out manually, and fax it to (xxx) xxx-xxx.
We estimate that it will take you less than one hour to complete this questionnaire. Please return the completed questionnaire by September 9, 2005.
Thank you for your assistance.
NOTE: For this survey, “diversion investigations” refers only to criminal/civil/complaint investigations, not scheduled or cyclic investigations.
A. BACKGROUND INFORMATION
B. ORGANIZATION OF YOUR GROUP
How many of each of the following authorized positions is assigned to your group (including yourself)? (Enter a number in each row. If your group has no positions for a particular position, enter “0”.)
How many, if any, vacant positions do you currently have for each of the following in your group?
(Enter a number in each row. If your group has no vacancies for a particular position, enter “0”.)
Approximately what percentage of time does your group spend on the following?
(Enter a percentage in each row. The column total should equal 100%.)
C. LAW ENFORCEMENT SUPPORT FOR DIVERSION INVESTIGATIONS
Which of the following best describes the involvement of DEA special agents in your group’s diversion investigations? (Check one box.)
Which of the following best describes the availability of law enforcement support that you receive from DEA special agents? (Check one box.)
Which of the following best describes the amount of law enforcement support that your group receives from DEA special agents? (Check one box.)
How satisfied are you with the law enforcement support that your group receives from DEA special agents? (Check one box.)
7a. If you answered “Not at all satisfied” to Q7, explain why: ______________
Which of the following best describes the involvement of local/state/other federal law enforcement personnel that assist in your group’s diversion investigations? (Check one box.)
What type of law enforcement personnel do you work with most often to support your group’s diversion investigations? (Check one box.)
In 2005, approximately how many of the controlled pharmaceutical diversion investigations conducted by your group required some type of law enforcement support? (Check one box.)
Since 2002, would you say that the need for law enforcement support in diversion investigations for your group has increased, stayed the same, or decreased? (Check one box.)
D. INTELLIGENCE SUPPORT FOR DIVERSION INVESTIGATIONS
The following section asks about your familiarity and use of the following:
- ARCOS – DEA’s Automation of Reports and Consolidated Orders System
- [REDACTED] – database provided by ChoicePoint
- AutoTrack – database provided by ChoicePoint
- Lexis/Nexis
- FinCEN – Financial Crimes Enforcement Network
- 1-877-RX-ABUSE – toll-free number allowing public to report suspicious Internet pharmacies
- UMPIRE – Unlawful Internet Pharmaceutical Sales Reporting system used to report suspicious Internet pharmacies on-line through DEA’s website
How familiar is your group with the information contained in the following? (Check one box in each row.)
Which of the following does your group have access to in your field office? (Check all that apply.)
How useful is the information contained in the following for your group’s diversion investigations?
(Check one box in each row.)
In 2005, in how many diversion investigations did your group use the following? (Check one box in each row.)
Has the E-Commerce Section (which includes E-Commerce Operations, E-Commerce Operational Support Unit and the Targeting and Analysis Unit) in the Office of Diversion Control in headquarters ever contacted your group with any proactive tips or leads developed through [REDACTED] or ARCOS? (Check one box in each row.)
Has your group ever received any tips or leads from the 1-877-RX-ABUSE hotline or UMPIRE to investigate?
(Check one box in each row.)
Have tips or leads received from any of the following sources initiated a diversion investigation for your group? (Check one box in each row.)
Which of the following best describes the involvement of DEA intelligence analysts in the field with diversion investigations for your group? (Check one box.)
Which of the following best describes the availability of intelligence support that your group receives from DEA intelligence analysts in the field? (Check one box.)
Which of the following best describes the amount of intelligence support that your group receives from DEA intelligence analysts in the field? (Check one box.)
Which of the following statements represent the types of DEA intelligence that your group receives from DEA headquarters or from the field? (Check all that apply.)
For what types of diversion investigations would you be most likely to request intelligence support? (Check all that apply.)
How satisfied are you with the intelligence support that your group has received from the intelligence group in your office? (Check one box.)
24a. If you answered “Not at all satisfied” to Q24, explain why: ________________
In 2005, approximately how many of the controlled pharmaceutical investigations conducted by your group required some type of intelligence support? (Check one box.)
Since 2002, would you say that the need for intelligence support in diversion investigations for your group has increased, stayed the same, or decreased? (Check one box.)
-
Describe any additional intelligence resources (e.g., access to investigative leads, intelligence analysts, or databases) necessary for your group to conduct diversion investigations: (Describe:) _______________________
E. DIVERSION INVESTIGATIONS
The following section asks about your interaction with the Special Operations Division (SOD) in headquarters and your familiarity with its Webcrawler program/Online Investigations Project. The Webcrawler program/Online Investigations Project allows SOD to provide data, such as IP address and registration information, regarding specific websites or email addresses.
In 2005, how many of the following diversion investigations has your group initiated?
(Enter a number in each row.)
Since 2002, would you say that the number of the following diversion investigations that your group has conducted has increased, stayed the same, or decreased? (Check one box in each row.)
Do you contact the Special Operations Division prior to initiating an Internet investigation?
(Check one box.)
Has the Special Operations Division ever provided your group with information gathered through the Webcrawler? (Check one box.)
31a. If you answered “Yes” to Q31, how satisfied were you with the Webcrawler information that was provided? (Check one box.)
Which of the following types of undercover equipment does your group have for conducting Internet investigations? (Check all that apply.)
Which of the following types of undercover equipment has your group used for conducting Internet investigations? (Check all that apply.)
33b. If you have not used any of the undercover equipment in Q33, please explain why:
(Describe:)_______________
Describe any additional resources that are necessary for your group to conduct the following investigations. (Describe in each row.)
In 2005, how many cases involving controlled pharmaceutical diversion from your group have been presented and accepted by the U.S. Attorneys’ Office? (Enter a number in each row.)
F. TRAINING
Other than the Basic Diversion Investigator Training Course received by all diversion investigators, which of the following additional training courses have been taken by diversion investigators in your group? (Check all that apply)
How adequate is the training that the diversion investigators in your group have received?
(Check one box.)
37a. If you answered “Not adequate” to Q37, what additional training would be useful for diversion investigators in your group? (Describe:)
Have the diversion investigators in your group received any specific training regarding how to prepare cases for the U.S. Attorneys’ Office? (Check one box.)
38a. If you answered “No” to Q38, please describe any additional resources that the diversion investigators in your group have access to for assistance in preparing cases for the U.S. Attorneys’ Office? (Describe:) __________________
G. CONCLUSION
In your opinion, how true are each of the following statements? (Check one box in each row.)
|